Canadian Drug Company Reports Positive Result On HIV Drug For Fat Disorder
Posted on June 19, 2008
Filed Under 365Gay, News
(Montreal, Quebec) Theratechnologies Inc. has reported positive results in a confirmatory Phase 3 clinical trial of its lead compound, tesamorelin, in patients with HIV-associated lipodystrophy.
Comments
Leave a Reply
